aTyr Pharma, Inc. Common Stock (NASDAQ: ATYR) last traded at $0.502, down 0.20% on the session. The quote above updates while this page is open; the figures below are drawn from aTyr Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
aTyr Pharma, Inc. Common Stock trades on NASDAQ under the ticker ATYR. Its market capitalisation is $49.24 million.
Valuation measures for aTyr Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $49.24M |
|---|---|
| Price / sales | 259.16 |
| Price / book | 1.01 |
| Beta | 1.75 |
Trailing-twelve-month figures tagged in aTyr Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $190.0K |
|---|---|
| Net income (TTM) | -$60.81M |
| EPS (TTM) | -$0.630 |
| Operating margin | -33609.47% |
| Return on equity | -124.64% |
| Cash | $16.16M |
Range and volume for ATYR over the past 52 weeks.
| 52-week high | $6.50 |
|---|---|
| 52-week low | $0.395 |
| Volume | 500.4K |
| Average volume | 1.80M |
| Previous close | $0.503 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.